# Trade Mark Journal No.2025/029 18 July 2025

## WO0000001861779 (1,5,9,42,44)

Office of origin: United States of America

Date of International Registration:8 May 2025
Date of designation in the UK: 8 May 2025

International priority date claimed: 30 April 2025 (United States of America) (99163948)

Class 1
  Chemical and biochemical reagents, assays and kits comprising chemical and biochemical reagents for scientific research use; chemical and biochemical reagents, assays and kits comprising chemical and biochemical reagents for medical research use; chemical and biochemical reagents, assays and kits comprising chemical and biochemical reagents for clinical laboratory use.
Class 5
  Chemical and biochemical reagents, assays and kits comprising chemical and biochemical reagents for medical and clinical use.
Class 9
  Downloadable and recorded computer software for collection, analysis, management, and reporting on test data; downloadable and recorded computer software for use in transplantation.
Class 42
  Software as a Service (SaaS) services featuring computer software for collection, analysis, and management and reporting on test data; Software as a Service (SaaS) services featuring software for use in transplantation.
Class 44
  Medical and health services relating to dna, genetics and genetic testing; genetic testing for medical purposes; customized healthcare services, namely, the development and provision of customized laboratory, medical, clinical, research, and genetic testing kits.

Omixon Biocomputing Kft.

Representative: Deborah J. Peckham Barclay Damon LLP, 160 Federal Street, Suite 1001, Boston MA 02110, UNITED STATES OF AMERICA